Dr. Robert H. Burke Announces the Newly F.D.A. Approved UltraSmooth Cellulite Treatment is Now Available at the Michigan Center for Cosmetic Surgery

Ann Arbor, MI, October 30, 2018 --(PR.com)-- Dr. Robert Burke, director of the Michigan Center for Cosmetic Surgery announces the addition of UltraSmooth cellulite treatment. “As more and more women request noninvasive cellulite treatment, a decision was made to offer this unique, newly approved FDA system for our patients. UltraSmooth cellulite treatment incorporates both the power of photonic energy and kinetic energy to reduce the appearance of cellulite,” says Dr.Burke.

Cellulite causes unsightly skin dimpling on women's hips and thighs. Over the years, there have been many different methods to remove cellulite from the body including those involving invasive and painful procedures. According to Dr. Burke, “UltraSmooth, using light therapy has the advantages of being noninvasive. No medication or anesthetic is needed. Results are immediately noticeable after treatment and there is no recovery time.”

The Michigan Center for Cosmetic Surgery, directed by Robert H. Burke, MD, FACS is committed to noninvasive and minimally invasive procedures, providing solutions to those seeking ambulatory treatment. The Ultra Smooth cellulite treatment complements these options which include the Ultra Slim for immediate subcutaneous fat reduction and the Silhouette Instalift, an alternative to the facelift.

Dr. Burke is a clinical professor or plastic and reconstructive surgery at Michigan State University as well as a clinical professor of facial plastic surgery. He is a principal investigator in FDA breast implant studies for Allergan and Mentor corporations.

He is also a researcher for laser tattoo removal, cold light lasers, and smart lipo lasers.

www.robertburke.com